Back
Genpact Vs. Vaxcyte Industry Stock Comparison
Sell
27
G
Genpact
Last Price:
$47.09
Seasonality Move:
5.87%
Sell
10
PCVX
Vaxcyte
Last Price:
$31.52
Seasonality Move:
12.17%
Sell
27
Genpact (G)
is a Sell
Is Genpact a Buy, Sell or Hold?
-
G is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
G Stock Price Chart
PCVX Stock Price Chart
G Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 31.63 | Sell |
Chaikin Money Flow: | -1434763 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.19 - 51.73) | Sell |
Bollinger Bands (100): | (43.78 - 51.44) | Sell |
PCVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.62 | Sell |
Relative Strength Index (14 RSI): | 17.1 | Sell |
Chaikin Money Flow: | 588768 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.86 - 80.84) | Sell |
Bollinger Bands (100): | (68.44 - 96.04) | Sell |
G Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.82 | Sell |
20-day SMA: | 50.01 | Sell |
50-day SMA: | 50.81 | Sell |
200-day SMA: | 41.97 | Buy |
8-day EMA: | 49.41 | Sell |
20-day EMA: | 50.11 | Sell |
50-day EMA: | 49.7 | Sell |
200-day EMA: | 43.89 | Buy |
PCVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.83 | Sell |
20-day SMA: | 62.86 | Sell |
50-day SMA: | 75.23 | Sell |
200-day SMA: | 88 | Sell |
8-day EMA: | 43.66 | Sell |
20-day EMA: | 57.73 | Sell |
50-day EMA: | 70.53 | Sell |
200-day EMA: | 81.17 | Sell |
Genpact Earnings Growth & G Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.32 per share, and an increase next year of $0.36 per share.
Vaxcyte Earnings Growth & PCVX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.37 per share.
Genpact Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vaxcyte Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |